Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSanofi Share News (SAN.PA)

Share Price Information for Sanofi (SAN.PA)

Euronext Paris
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 89.94
Bid: 93.35
Ask: 93.36
Change: 0.08 (0.089%)
Spread: 0.01 (0.011%)
Open: 90.23
High: 90.59
Low: 89.73
Prev. Close: 89.86
SAN.PA Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

European stocks log steepest one-day fall this year as banks extend slide

Mon, 13th Mar 2023 17:13

European banks log worst two-day selloff in a year

*

Credit Suisse tumbles to fresh record low

*

HSBC rescues Silicon Valley Bank's UK arm

*

Energy firms dip on lower oil prices

March 13 (Reuters) - European stocks logged their steepest one-day fall this year on Monday on continued drag from banking stocks even as authorities stepped in to limit the fallout from the sudden collapse of Silicon Valley Bank.

The pan-European STOXX 600 index closed the day 2.3% lower, with bank, financials and insurer stocks, along with energy stocks, bearing the brunt of selling pressure.

European banking stocks dropped 5.7%, notching their worst two-day selloff since the Russia-Ukraine war broke out early last year.

Worries around the resilience of the sector's balance sheet in the face of SVB's collapse have rattled investors.

"Investors have been shaken by the events of the past few days, and are waiting with bated breath to see if repercussions in the financial sector will spill over and create pools of fresh problems," said Susannah Streeter, head of money and markets at Hargreaves Lansdown.

The wider risk-off moves sent Credit Suisse shares down 9.6% to a fresh record low.

Germany's Commerzbank slumped 12.7%, France's Societe Generale and Spain's Sabadell fell 6.2% and 11.4%, respectively.

HSBC dropped 4.1% after the British bank acquired the UK subsidiary of SVB for 1 pound, rescuing a key lender for technology start-ups in Britain.

However, euro zone banking supervisors saw limited consequences for the region's banks from the collapse of the U.S. lenders, while Moody's Investors Service noted that Europe's banks were unlikely to get hit by bond portfolio losses.

In addition, Morgan Stanley analysts noted that strong liquidity in European banks' balance sheet structure should avoid any forced unwinding or selling of bond portfolios.

The Federal Reserve and U.S. Treasury have announced a range of measures to stabilise the banking system and said SVB depositors would have access to their deposits on Monday.

Meanwhile, the stress in the financial sector has sparked expectations of a slowdown in the Fed's aggressive monetary tightening, with investors seeing a 68% chance of a 25 basis points (bps) hike next week, a drastic change from the 50-bps hike priced in previously.

Goldman Sachs no longer expects a rate hike from the Fed.

On the other hand, the ECB looks set to hike rates by 50 bps later this week.

Among others, Shell, BP and TotalEnergies SE lost between 4% and 5% tracking lower oil prices.

France's Sanofi SA dropped 1.7% on plans to acquire Provention Bio Inc for $2.9 billion. (Reporting by Sruthi Shankar and Ankika Biswas in Bengaluru; Editing by Savio D'Souza, Uttaresh Venkateshwaran and Christina Fincher)

More News
10 Nov 2022 16:34

Sanofi, GSK score late win with EU COVID booster approval

Nov 10 (Reuters) - Sanofi said on Thursday it won European Union approval for its COVID-19 vaccine booster, jointly made with British partner GSK, after a drawn-out development effort that saw the pair fall behind now-dominant vaccine suppliers.

Read more
4 Nov 2022 07:00

Sanofi, Astra win EU approval for prevention of infant RSV

Nov 4 (Reuters) - The European Commission on Friday approved Sanofi and AstraZeneca's Beyfortus for the prevention of a common and highly contagious type of respiratory infections in infants.

Read more
2 Nov 2022 15:47

New GSK maintains strong start, but Zantac litigation looms large

Q3 profit, sales beat expectations

*

Read more
29 Sep 2022 11:44

Oddo BHF flags European pharma's attractive growth profile, prefers Novo Nordisk, AstraZeneca

Read more
26 Sep 2022 15:22

GSK selects Burberry's Brown as its first female CFO

Brown to join GSK in April

*

Read more
20 Sep 2022 08:58

Haleon believes it is not liable for any potential Zantac liabilities

LONDON, Sept 20 (Reuters) - Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac, the London-listed company's CEO Brian McNamara told Reuters on Tuesday.

Read more
20 Sep 2022 07:14

Haleon rejects Zantac indemnification requests from GSK, Pfizer

LONDON, Sept 20 (Reuters) - Haleon on Tuesday said it had notified GSK and Pfizer that it had rejected their requests for indemnification in relation to U.S.-based litigation over the heartburn drug, Zantac.

Read more
5 Sep 2022 15:24

Sanofi sees EU regulatory decision on its COVID booster in weeks

BRUSSELS, Sept 5 (Reuters) - The European Union's drugs regulator may be a few weeks from deciding whether to approve the experimental COVID-19 vaccine developed by French drugmaker Sanofi and its British partner GSK, a Sanofi executive said on Monday.

Read more
30 Aug 2022 17:14

European stocks fall for third day as rate hike, recession fears grow

Aug 30 (Reuters) - European shares ended lower on Tuesday, failing to shrug off fears of higher interest rates amid a burgeoning energy crisis and looming recession.

Read more
17 Aug 2022 18:10

Sanofi trial failure halts work on breast cancer treatment amcenestrant

Aug 17 (Reuters) - Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial potential in breast cancer, after a second trial failure dealt a major blow to the French healthcare company's development prospects.

Read more
17 Aug 2022 17:22

European shares slip on inflation worries, Germany leads fall

Aug 17 (Reuters) - European shares slid on Wednesday and bond yields rallied after a sharp rise in UK inflation brought the spotlight back to more monetary tightening amid data which showed euro zone economic growth was slightly less robust in the second quarter.

Read more
17 Aug 2022 15:15

Plaintiff in first Zantac lawsuit set for trial drops case

Aug 17 (Reuters) - The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants.

Read more
17 Aug 2022 08:21

GSK shares ease after plaintiff in first Zantac lawsuit drops case

LONDON, Aug 17 (Reuters) - Shares in GlaxoSmithKline fell slightly in early trading on Wednesday but stayed above recent lows after the plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial agreed to drop his case.

Read more
15 Aug 2022 22:17

UK first to approve Omicron COVID shot with Moderna nod

LONDON, Aug 15 (Reuters) - Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.

Read more
12 Aug 2022 17:17

European shares rise as healthcare, leisure stocks gain

Aug 12 (Reuters) - European shares rose on Friday after drugmakers rebounded following a slump in the previous session, and Flutter fanned a rally in the travel and leisure sector after an upbeat earnings forecast.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.